Concepts (225)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Atherosclerosis | 19 | 2023 | 3445 | 1.910 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 10 | 2022 | 3255 | 1.200 |
Why?
|
Coronary Artery Disease | 11 | 2023 | 6485 | 1.150 |
Why?
|
Medication Adherence | 9 | 2021 | 2063 | 1.050 |
Why?
|
Cardiovascular Diseases | 19 | 2023 | 15142 | 0.970 |
Why?
|
Peripheral Arterial Disease | 4 | 2021 | 1188 | 0.800 |
Why?
|
Cardiology | 5 | 2023 | 1668 | 0.740 |
Why?
|
Rheumatic Fever | 1 | 2020 | 71 | 0.720 |
Why?
|
Veterans | 7 | 2023 | 2519 | 0.720 |
Why?
|
Myocardial Ischemia | 6 | 2023 | 2150 | 0.680 |
Why?
|
Echocardiography, Stress | 1 | 2020 | 131 | 0.680 |
Why?
|
Myocardial Infarction | 10 | 2023 | 11708 | 0.620 |
Why?
|
Drug-Eluting Stents | 3 | 2019 | 753 | 0.610 |
Why?
|
Healthcare Disparities | 5 | 2021 | 3155 | 0.600 |
Why?
|
Angina Pectoris | 2 | 2021 | 977 | 0.570 |
Why?
|
Aortic Valve Insufficiency | 1 | 2021 | 579 | 0.570 |
Why?
|
Absorbable Implants | 1 | 2019 | 336 | 0.570 |
Why?
|
Meta-Analysis as Topic | 1 | 2021 | 1340 | 0.560 |
Why?
|
Fibrinolytic Agents | 3 | 2020 | 2159 | 0.530 |
Why?
|
Shock, Cardiogenic | 5 | 2023 | 688 | 0.510 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2020 | 555 | 0.480 |
Why?
|
Periodicals as Topic | 2 | 2021 | 1429 | 0.440 |
Why?
|
Dyslipidemias | 1 | 2020 | 851 | 0.440 |
Why?
|
Exercise Test | 1 | 2020 | 2074 | 0.420 |
Why?
|
Heart Valve Prosthesis | 1 | 2021 | 1489 | 0.420 |
Why?
|
Aspirin | 3 | 2020 | 3283 | 0.400 |
Why?
|
Platelet Aggregation Inhibitors | 3 | 2021 | 3070 | 0.390 |
Why?
|
Guideline Adherence | 3 | 2020 | 2265 | 0.380 |
Why?
|
Ambulatory Care | 2 | 2020 | 2707 | 0.350 |
Why?
|
Antihypertensive Agents | 1 | 2018 | 2047 | 0.330 |
Why?
|
United States Department of Veterans Affairs | 4 | 2021 | 875 | 0.330 |
Why?
|
Risk Assessment | 9 | 2022 | 23327 | 0.320 |
Why?
|
Diabetes Mellitus, Type 2 | 5 | 2023 | 11729 | 0.310 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2020 | 2104 | 0.310 |
Why?
|
Journal Impact Factor | 2 | 2019 | 155 | 0.300 |
Why?
|
Behavioral Risk Factor Surveillance System | 6 | 2022 | 199 | 0.280 |
Why?
|
Coronary Vessel Anomalies | 2 | 2021 | 314 | 0.280 |
Why?
|
Brain Ischemia | 1 | 2020 | 3264 | 0.270 |
Why?
|
Humans | 70 | 2023 | 743811 | 0.270 |
Why?
|
Treatment Outcome | 18 | 2023 | 63042 | 0.250 |
Why?
|
Telemedicine | 2 | 2021 | 2874 | 0.250 |
Why?
|
Substance-Related Disorders | 1 | 2021 | 4254 | 0.240 |
Why?
|
American Heart Association | 4 | 2023 | 1057 | 0.240 |
Why?
|
United States | 26 | 2023 | 69859 | 0.240 |
Why?
|
Sex Factors | 7 | 2021 | 10394 | 0.220 |
Why?
|
Hospital Mortality | 4 | 2021 | 5316 | 0.220 |
Why?
|
Risk Factors | 16 | 2022 | 72252 | 0.220 |
Why?
|
Ultrasonography, Interventional | 2 | 2023 | 1486 | 0.220 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7270 | 0.210 |
Why?
|
Secondary Prevention | 4 | 2022 | 1529 | 0.210 |
Why?
|
Colchicine | 2 | 2020 | 244 | 0.210 |
Why?
|
Prevalence | 6 | 2021 | 15211 | 0.210 |
Why?
|
Hypertension | 4 | 2021 | 8480 | 0.200 |
Why?
|
Cross-Sectional Studies | 9 | 2021 | 25032 | 0.200 |
Why?
|
Septal Occluder Device | 1 | 2022 | 128 | 0.190 |
Why?
|
Vascular Diseases | 2 | 2021 | 1161 | 0.190 |
Why?
|
Coronary Angiography | 3 | 2023 | 4576 | 0.180 |
Why?
|
Middle Aged | 21 | 2022 | 213241 | 0.180 |
Why?
|
Drug Prescriptions | 2 | 2020 | 1636 | 0.180 |
Why?
|
Aged | 19 | 2022 | 163178 | 0.180 |
Why?
|
Coronary Disease | 3 | 2023 | 6078 | 0.180 |
Why?
|
Unsafe Sex | 1 | 2021 | 220 | 0.170 |
Why?
|
Male | 29 | 2023 | 349776 | 0.170 |
Why?
|
Foramen Ovale, Patent | 1 | 2022 | 223 | 0.170 |
Why?
|
Budgets | 1 | 2020 | 229 | 0.160 |
Why?
|
Florida | 1 | 2020 | 435 | 0.160 |
Why?
|
Veterans Health | 1 | 2020 | 216 | 0.160 |
Why?
|
Female | 29 | 2022 | 380020 | 0.160 |
Why?
|
Heart Failure | 5 | 2023 | 10896 | 0.160 |
Why?
|
Herpes Zoster Oticus | 1 | 2017 | 8 | 0.150 |
Why?
|
Bibliometrics | 1 | 2021 | 338 | 0.150 |
Why?
|
Hypertriglyceridemia | 1 | 2021 | 295 | 0.150 |
Why?
|
Fever of Unknown Origin | 1 | 2018 | 93 | 0.150 |
Why?
|
Acute Coronary Syndrome | 2 | 2021 | 2337 | 0.150 |
Why?
|
Substance Abuse, Intravenous | 1 | 2021 | 525 | 0.140 |
Why?
|
Lymphoma, T-Cell, Peripheral | 1 | 2018 | 134 | 0.140 |
Why?
|
Atrial Fibrillation | 3 | 2021 | 5033 | 0.130 |
Why?
|
Stroke | 5 | 2022 | 9975 | 0.130 |
Why?
|
Hypoglycemic Agents | 3 | 2022 | 2877 | 0.130 |
Why?
|
Tobacco Use Disorder | 1 | 2021 | 688 | 0.130 |
Why?
|
Hyperlipoproteinemia Type II | 1 | 2020 | 375 | 0.130 |
Why?
|
Vitamin K | 1 | 2017 | 295 | 0.130 |
Why?
|
Age Factors | 6 | 2021 | 18355 | 0.130 |
Why?
|
Myocardial Revascularization | 1 | 2019 | 841 | 0.130 |
Why?
|
Office Visits | 1 | 2019 | 598 | 0.130 |
Why?
|
Blood Pressure Determination | 1 | 2018 | 633 | 0.120 |
Why?
|
Anticoagulants | 3 | 2021 | 4599 | 0.120 |
Why?
|
Drug Utilization | 1 | 2020 | 1183 | 0.120 |
Why?
|
Adult | 15 | 2022 | 213889 | 0.120 |
Why?
|
Thrombolytic Therapy | 2 | 2020 | 2162 | 0.120 |
Why?
|
Peripheral Vascular Diseases | 1 | 2017 | 549 | 0.120 |
Why?
|
Patient Preference | 1 | 2020 | 889 | 0.110 |
Why?
|
Prosthesis Implantation | 1 | 2018 | 640 | 0.110 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2019 | 9944 | 0.110 |
Why?
|
Facial Paralysis | 1 | 2017 | 338 | 0.110 |
Why?
|
Epidemiologic Methods | 1 | 2018 | 1364 | 0.110 |
Why?
|
Diabetes Complications | 1 | 2020 | 1360 | 0.110 |
Why?
|
Life Style | 2 | 2021 | 3833 | 0.110 |
Why?
|
Cardiovascular Agents | 1 | 2019 | 850 | 0.110 |
Why?
|
Proliferating Cell Nuclear Antigen | 2 | 2023 | 286 | 0.110 |
Why?
|
Risk Reduction Behavior | 1 | 2019 | 1125 | 0.110 |
Why?
|
Pandemics | 3 | 2021 | 8385 | 0.110 |
Why?
|
Aged, 80 and over | 7 | 2021 | 57744 | 0.100 |
Why?
|
Coronary Stenosis | 1 | 2018 | 833 | 0.100 |
Why?
|
Mitral Valve Insufficiency | 1 | 2022 | 1421 | 0.100 |
Why?
|
Anemia | 1 | 2021 | 1502 | 0.100 |
Why?
|
Medicaid | 2 | 2021 | 2736 | 0.100 |
Why?
|
Registries | 3 | 2022 | 8090 | 0.100 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2022 | 1537 | 0.100 |
Why?
|
Tomography, Optical Coherence | 1 | 2023 | 2657 | 0.090 |
Why?
|
Alcoholism | 1 | 2021 | 1907 | 0.090 |
Why?
|
Patient Readmission | 2 | 2022 | 3117 | 0.090 |
Why?
|
Heart Diseases | 1 | 2023 | 2789 | 0.090 |
Why?
|
Surgery, Computer-Assisted | 1 | 2018 | 1017 | 0.090 |
Why?
|
Hodgkin Disease | 1 | 2018 | 1415 | 0.090 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2021 | 2200 | 0.090 |
Why?
|
Health Status Disparities | 1 | 2021 | 1796 | 0.090 |
Why?
|
Hospitals | 1 | 2023 | 3953 | 0.090 |
Why?
|
Acute Kidney Injury | 1 | 2022 | 1968 | 0.090 |
Why?
|
Academic Medical Centers | 1 | 2020 | 2760 | 0.090 |
Why?
|
Delivery of Health Care | 3 | 2021 | 5319 | 0.080 |
Why?
|
Comorbidity | 5 | 2021 | 10380 | 0.080 |
Why?
|
Mortality | 1 | 2020 | 2862 | 0.080 |
Why?
|
Internet | 1 | 2020 | 3058 | 0.080 |
Why?
|
Endovascular Procedures | 1 | 2021 | 1980 | 0.080 |
Why?
|
Attention | 1 | 2018 | 2393 | 0.080 |
Why?
|
Evidence-Based Medicine | 1 | 2020 | 3608 | 0.080 |
Why?
|
Odds Ratio | 1 | 2020 | 9848 | 0.080 |
Why?
|
Insurance, Health | 1 | 2020 | 2492 | 0.070 |
Why?
|
Incidence | 3 | 2021 | 20948 | 0.070 |
Why?
|
Cost-Benefit Analysis | 1 | 2020 | 5388 | 0.070 |
Why?
|
Coronary Vessels | 1 | 2018 | 3106 | 0.070 |
Why?
|
Attitude of Health Personnel | 1 | 2020 | 3839 | 0.070 |
Why?
|
Time Factors | 4 | 2021 | 40038 | 0.070 |
Why?
|
Ventricular Function, Left | 1 | 2019 | 3660 | 0.070 |
Why?
|
Hyperlipidemias | 2 | 2021 | 789 | 0.070 |
Why?
|
Stents | 1 | 2018 | 3280 | 0.070 |
Why?
|
Aortic Valve Stenosis | 1 | 2018 | 1955 | 0.070 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2021 | 2428 | 0.070 |
Why?
|
Stroke Volume | 1 | 2019 | 5002 | 0.070 |
Why?
|
Immunosuppressive Agents | 1 | 2019 | 4152 | 0.070 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3134 | 0.070 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3241 | 0.070 |
Why?
|
Databases, Factual | 4 | 2021 | 7729 | 0.060 |
Why?
|
Thrombosis | 1 | 2019 | 2968 | 0.060 |
Why?
|
Health Services Accessibility | 1 | 2021 | 5136 | 0.060 |
Why?
|
Hospitalization | 2 | 2021 | 10259 | 0.060 |
Why?
|
Catheter Ablation | 1 | 2017 | 2758 | 0.060 |
Why?
|
Primary Health Care | 1 | 2019 | 4556 | 0.060 |
Why?
|
Blood Pressure | 1 | 2018 | 8551 | 0.050 |
Why?
|
Biomedical Research | 1 | 2018 | 3308 | 0.050 |
Why?
|
Young Adult | 4 | 2022 | 56392 | 0.050 |
Why?
|
Phenylephrine | 1 | 2022 | 301 | 0.050 |
Why?
|
Aging | 1 | 2020 | 8655 | 0.050 |
Why?
|
Cohort Studies | 2 | 2021 | 40545 | 0.050 |
Why?
|
Inflammation | 1 | 2020 | 10629 | 0.050 |
Why?
|
Mediastinum | 1 | 2022 | 267 | 0.050 |
Why?
|
Tobacco, Smokeless | 1 | 2021 | 130 | 0.050 |
Why?
|
Hospital Charges | 1 | 2021 | 362 | 0.040 |
Why?
|
Drug Therapy, Combination | 2 | 2020 | 6487 | 0.040 |
Why?
|
Limb Salvage | 1 | 2021 | 433 | 0.040 |
Why?
|
Cardiotonic Agents | 1 | 2022 | 535 | 0.040 |
Why?
|
Obesity | 1 | 2021 | 12744 | 0.040 |
Why?
|
Receptors, Interleukin-6 | 1 | 2020 | 225 | 0.040 |
Why?
|
Diabetes Mellitus | 3 | 2021 | 5752 | 0.040 |
Why?
|
Geography | 1 | 2020 | 669 | 0.040 |
Why?
|
General Practice | 1 | 2019 | 100 | 0.040 |
Why?
|
Reed-Sternberg Cells | 1 | 2018 | 73 | 0.040 |
Why?
|
Hyperbilirubinemia | 1 | 2018 | 77 | 0.040 |
Why?
|
Diet, Sodium-Restricted | 1 | 2019 | 287 | 0.040 |
Why?
|
Hemorrhage | 2 | 2020 | 3458 | 0.040 |
Why?
|
Appointments and Schedules | 1 | 2019 | 417 | 0.030 |
Why?
|
Risk-Taking | 1 | 2021 | 986 | 0.030 |
Why?
|
Eicosapentaenoic Acid | 1 | 2020 | 581 | 0.030 |
Why?
|
Nutrition Surveys | 1 | 2021 | 1660 | 0.030 |
Why?
|
Vagus Nerve | 1 | 2017 | 439 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3268 | 0.030 |
Why?
|
Cholesterol, HDL | 1 | 2021 | 1813 | 0.030 |
Why?
|
Chest Pain | 1 | 2021 | 1114 | 0.030 |
Why?
|
Employment | 1 | 2020 | 1132 | 0.030 |
Why?
|
Eosinophilia | 1 | 2018 | 541 | 0.030 |
Why?
|
Primary Prevention | 1 | 2021 | 1167 | 0.030 |
Why?
|
Medicare | 2 | 2022 | 6565 | 0.030 |
Why?
|
Mitral Valve | 1 | 2022 | 1491 | 0.030 |
Why?
|
Physicians, Primary Care | 1 | 2019 | 592 | 0.030 |
Why?
|
Neoplasms | 1 | 2022 | 21675 | 0.030 |
Why?
|
Ischemia | 1 | 2021 | 1907 | 0.030 |
Why?
|
Anticholesteremic Agents | 1 | 2020 | 979 | 0.030 |
Why?
|
Educational Status | 1 | 2020 | 2540 | 0.030 |
Why?
|
Retrospective Studies | 4 | 2022 | 77410 | 0.030 |
Why?
|
Cholesterol, LDL | 1 | 2021 | 2354 | 0.030 |
Why?
|
Qualitative Research | 1 | 2020 | 2682 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2022 | 2583 | 0.020 |
Why?
|
Intracranial Hemorrhages | 1 | 2017 | 855 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2018 | 2103 | 0.020 |
Why?
|
Self Report | 1 | 2022 | 3550 | 0.020 |
Why?
|
Information Dissemination | 1 | 2019 | 1099 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2020 | 2278 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2020 | 3208 | 0.020 |
Why?
|
Glucose | 1 | 2022 | 4398 | 0.020 |
Why?
|
Administration, Oral | 1 | 2017 | 3912 | 0.020 |
Why?
|
Recurrence | 1 | 2021 | 8337 | 0.020 |
Why?
|
Inpatients | 1 | 2021 | 2515 | 0.020 |
Why?
|
Recovery of Function | 1 | 2019 | 2922 | 0.020 |
Why?
|
Critical Illness | 1 | 2021 | 2670 | 0.020 |
Why?
|
Chronic Disease | 1 | 2023 | 9139 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 10940 | 0.020 |
Why?
|
Length of Stay | 1 | 2021 | 6311 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2021 | 12243 | 0.020 |
Why?
|
Health Expenditures | 1 | 2020 | 2348 | 0.020 |
Why?
|
Smoking Cessation | 1 | 2019 | 2071 | 0.020 |
Why?
|
Communication | 1 | 2020 | 3748 | 0.020 |
Why?
|
Patient Selection | 1 | 2018 | 4210 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2018 | 3476 | 0.020 |
Why?
|
Biopsy | 1 | 2018 | 6750 | 0.020 |
Why?
|
Logistic Models | 1 | 2020 | 13404 | 0.020 |
Why?
|
Adolescent | 2 | 2022 | 85729 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 12954 | 0.010 |
Why?
|
Prognosis | 1 | 2021 | 29052 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 17439 | 0.010 |
Why?
|
Prospective Studies | 1 | 2022 | 53250 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39001 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 11524 | 0.010 |
Why?
|
Mutation | 1 | 2020 | 29777 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2017 | 35409 | 0.010 |
Why?
|
Concepts
(225)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(9)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_